University of Tasmania
Browse

File(s) not publicly available

Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor

Version 2 2024-09-17, 02:06
Version 1 2023-05-17, 08:08
journal contribution
posted on 2024-09-17, 02:06 authored by PA Kitchen, RA Goodlad, AJ FitzGerald, N Mandir, MA Ghatei, SR Bloom, J Berlanga-Acosta, RJ Playford, A Forbes, JRF Walters
Background: Parenteral nutrition and the absence of luminal feeding result in impaired intestinal growth and differentiation of enterocytes. Glucagon-like peptide 2 (GLP-2) and epidermal growth factor (EGF) have each been shown to have trophic effects on the intestine, and thus have the potential to benefit patients fed parenterally, such as those with intestinal failure from short bowel syndrome. We report studies aimed to determine whether there may be synergistic effects of these 2 peptides. Methods: Rats were established on parenteral nutrition (PN) and infused for 6 days with GLP-2 (20 μg/d), EGF (20 μg/d), or GLP-2 + EGF (20 μg/d of each). These groups were compared with untreated PN-fed and orally-fed controls. Tissue was obtained from small intestine and colon to determine growth, proliferation, and representative gene expression. Results: Small intestinal weight was increased by 75%, 43%, and 116% in the GLP-2, EGF, and GLP-2 + EGF groups, respectively, compared with PN controls (all p < .001). Cell proliferation increased with GLP-2, EGF, and GLP-2 + EGF in proximal small intestine by factors of 2.3, 1.7, and 3.4 respectively (p < .001). A synergistic effect on villous and crypt area was observed in the proximal small intestine when GLP-2 and EGF were combined (p < .05). GLP-2 had no effect in the colon, unlike EGF. Further studies showed GLP-2 + EGF significantly increased expression in distal small intestine of transcripts for the bile acid transport protein IBABP (p < .05) and showed a significant correlation between the expression of IBABP and the transcription factor HNF-4. Conclusions: Both GLP-2 and EGF upregulate growth of the small intestine, and this is augmented when GLP-2 and EGF are combined. These findings may lead to improved treatment of patients receiving PN. Copyright © 2005 by the American Society for Parenteral and Enteral Nutrition.

History

Publication title

Journal of Parenteral and Enteral Nutrition

Volume

29

Issue

4

Pagination

248-254

ISSN

0148-6071

Department/School

College Office - CHM

Publisher

Amer Soc Parenteral & Enteral Nutrition

Publication status

  • Published

Place of publication

8630 Fenton Street Suite 412, Silver Spring, USA, Md, 20910

Socio-economic Objectives

200199 Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC